Company
Wave Life Sciences Ltd. (WVE)
Standardized SEC financial data for Wave Life Sciences Ltd. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001631574 · NASDAQ · Pharmaceutical Preparations.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $20.1M | $41.0M | $3.6M | $113.3M | $108.3M | $42.7M |
| R&D expense | $130.9M | $121.9M | $115.9M | $130.0M | $159.7M | $182.8M |
| SG&A expense | $42.5M | $46.1M |
Standardized from Wave Life Sciences Ltd.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Get WVE data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/WVE/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/WVE/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"